Herceptin Research Today is a free monthly online journal that collates and summarizes the latest research about Herceptin, including details on side-effects, breast cancer, treatment, therapy.

Volume 3 (2006), Issue 6 (June)

1. Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo.
   Cancer Res, 66(11): 5836-46. [Abstract] [Full-text]
2. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
   Crit Rev Oncol Hematol, 58(3): 242-56. [Abstract] [Full-text]
3. Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells.
   Biomaterials, 27(28): 4975-83. [Abstract] [Full-text]
4. Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: a multicenter phase II trial.
   J Clin Oncol, 24(18): 2773-8. [Abstract] [Full-text]
5. Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer.
   J Clin Oncol, 24(18): 2786-92. [Abstract] [Full-text]
6. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
   Semin Oncol, 33(3): 15-21. [Abstract] [Full-text]
7. HER-2 Status in Breast Cancer: Correlation of Gene Amplification by FISH With Immunohistochemistry Expression Using Advanced Cellular Imaging System.
   Appl Immunohistochem Mol Morphol, 14(2): 132-137. [Abstract] [Full-text]
8. The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin.
   Protein Eng Des Sel, 19(7): 291-7. [Abstract] [Full-text]
9. Overview of gemcitabine activity in advanced breast cancer.
   Semin Oncol, 33: 19-23. [Abstract] [Full-text]
10. HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial.
    J Clin Oncol, 24(19): 3032-8. [Abstract] [Full-text]

© 2004-2008 Herceptin Research Today. All Rights Reserved.